These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1353943)
1. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Pomerleau OF Am J Med; 1992 Jul; 93(1A):2S-7S. PubMed ID: 1353943 [TBL] [Abstract][Full Text] [Related]
2. Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Pomerleau OF; Pomerleau CS Neurosci Biobehav Rev; 1984; 8(4):503-13. PubMed ID: 6151160 [TBL] [Abstract][Full Text] [Related]
4. Plasma nicotine, plasma beta-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement. Wewers ME; Tejwani GA; Anderson J Psychopharmacology (Berl); 1994 Sep; 116(1):98-102. PubMed ID: 7862939 [TBL] [Abstract][Full Text] [Related]
5. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Herrera N; Franco R; Herrera L; Partidas A; Rolando R; Fagerström KO Chest; 1995 Aug; 108(2):447-51. PubMed ID: 7634882 [TBL] [Abstract][Full Text] [Related]
8. How effective is nicotine replacement therapy in helping people to stop smoking? Tang JL; Law M; Wald N BMJ; 1994 Jan; 308(6920):21-6. PubMed ID: 8179658 [TBL] [Abstract][Full Text] [Related]
9. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men. Mendelson JH; Goletiani N; Sholar MB; Siegel AJ; Mello NK Neuropsychopharmacology; 2008 Mar; 33(4):749-60. PubMed ID: 17507912 [TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine responses to nicotine and stress: enhancement of peripheral stress responses by the administration of nicotine. Morse DE Psychopharmacology (Berl); 1989; 98(4):539-43. PubMed ID: 2505296 [TBL] [Abstract][Full Text] [Related]
11. Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men. Mendelson JH; Sholar MB; Goletiani N; Siegel AJ; Mello NK Neuropsychopharmacology; 2005 Sep; 30(9):1751-63. PubMed ID: 15870834 [TBL] [Abstract][Full Text] [Related]
13. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Le Houezec J Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663 [TBL] [Abstract][Full Text] [Related]
15. Smoking, cortisol and nicotine. Steptoe A; Ussher M Int J Psychophysiol; 2006 Mar; 59(3):228-35. PubMed ID: 16337291 [TBL] [Abstract][Full Text] [Related]
16. Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders. Murphy CM; MacKillop J; Martin RA; Tidey JW; Colby SM; Rohsenow DJ Psychopharmacology (Berl); 2017 Aug; 234(16):2443-2452. PubMed ID: 28500373 [TBL] [Abstract][Full Text] [Related]
17. Nicotine as a typical drug of abuse in experimental animals and humans. Le Foll B; Goldberg SR Psychopharmacology (Berl); 2006 Mar; 184(3-4):367-81. PubMed ID: 16205918 [TBL] [Abstract][Full Text] [Related]